P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular DystrophyLizzia Raffaghello, Claudio Bruno, Santina Bruzzone et al.|Pharmaceuticals|2022Cited by 22
The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan–Deficient Muscular DystrophyElisabetta Gazzerro, Claudio Bruno, Serena Baratto et al.|American Journal Of Pathology|2018Cited by 18
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in SarcoglycanopathiesAndrea Benzi, Claudio Bruno, Serena Baratto et al.|Laboratory Investigation|2023Cited by 3
Genetic Deletion of the Purinergic Receptor <i>P2rx7</i> Worsens the Phenotype of α-Sarcoglycan Muscular DystrophyCecilia Astigiano, Elisabetta Gazzerro, Elisa Principi et al.|ACS Pharmacology & Translational Science|2025Cited by 1